跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cardizef - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cardizef
Approved
STANDARD
Cardizef
Dongkwang Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
51bd0af44e79c1f3
Company
Dongkwang Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
51bd0af44e79c1f3
Drug Approval Philippines Name
Cardizef
Product Name
Cardizef
Registration Number
DRP-8014-07
Brand Name
Cardizef
Generic Name
Nicardipine Hydrochloride
Dosage Form
Solution For Injection (Iv)
Dosage Strength
10mg/10mL (1mg/1mL)
Manufacturer
Dongkwang Pharm. Co., Ltd.
Importer
JLT Pharma, Inc.
Distributor
Metro Pharma Philippines Inc.
Company Detail Path
/organization/dongkwang-pharm-co-ltd
Issuance Date
25 May 2022
Expiry Date
17 August 2027
Pharmacologic Category
Dihydropyridine derivatives (Selective Calcium Channel Blockers with mainly vascular effects)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
51bd0af44e79c1f3
Type
Standard
Back to Philippines FDA Approvals